MBIO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Mustang Bio Inc (MBIO).


$12.44M Market Cap.

As of 03/11/2024 5:00 PM ET (MRY) • Disclaimer

MBIO Market Cap. (MRY)


MBIO Shares Outstanding (MRY)


MBIO Assets (MRY)


Total Assets

$17.74M

Total Liabilities

$17.62M

Total Investments

$0

MBIO Income (MRY)


Revenue

$0

Net Income

-$51.60M

Operating Expense

$49.26M

MBIO Cash Flow (MRY)


CF Operations

-$49.48M

CF Investing

$5.89M

CF Financing

-$26.08M

MBIO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

MBIO Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$17,742,000 (-80.80%)

$92,422,000 (-26.16%)

$125,170,000 (13.89%)

$109,900,000 (49.64%)

Assets Current

$11,346,000 (-85.61%)

$78,852,000 (-29.41%)

$111,706,000 (12.23%)

$99,534,000 (57.83%)

Assets Non-Current

$6,396,000 (-52.87%)

$13,570,000 (0.79%)

$13,464,000 (29.89%)

$10,366,000 (-0.15%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$123,000 (-99.73%)

$46,273,000 (-58.83%)

$112,400,000 (14.19%)

$98,435,000 (90.57%)

Property Plant & Equipment Net

$4,813,000 (-60.90%)

$12,309,000 (1.71%)

$12,102,000 (32.76%)

$9,116,000 (-0.18%)

Cash & Equivalents

$6,984,000 (-90.89%)

$76,656,000 (-30.70%)

$110,618,000 (11.96%)

$98,804,000 (58.31%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$270,000 (0.00%)

$270,000 (0.00%)

$270,000 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$3,879,000 (10675.00%)

$36,000 (-28.00%)

$50,000 (233.33%)

$15,000 (-21.05%)

Trade & Non-Trade Payables

$14,851,000 (2.44%)

$14,497,000 (38.50%)

$10,467,000 (13.32%)

$9,237,000 (47.46%)

Accumulated Retained Earnings (Deficit)

-$380,971,000 (-15.67%)

-$329,369,000 (-30.78%)

-$251,844,000 (-35.78%)

-$185,474,000 (-47.84%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$2,498,000 (-92.04%)

$31,382,000 (1443.63%)

$2,033,000 (-8.75%)

$2,228,000 (-85.65%)

Debt Current

$520,000 (-15.03%)

$612,000 (75.86%)

$348,000 (25.18%)

$278,000 (-81.55%)

Debt Non-Current

$1,978,000 (-93.57%)

$30,770,000 (1726.11%)

$1,685,000 (-13.59%)

$1,950,000 (-86.09%)

Total Liabilities

$17,619,000 (-61.82%)

$46,149,000 (261.39%)

$12,770,000 (11.38%)

$11,465,000 (-47.39%)

Liabilities Current

$15,371,000 (1.73%)

$15,109,000 (39.70%)

$10,815,000 (13.66%)

$9,515,000 (22.44%)

Liabilities Non-Current

$2,248,000 (-92.76%)

$31,040,000 (1487.72%)

$1,955,000 (0.26%)

$1,950,000 (-86.09%)

MBIO Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,686,000 (-20.67%)

$12,210,000 (10.83%)

$11,017,000 (15.91%)

$9,505,000 (-0.68%)

Research & Development Expense

$41,040,000 (-35.82%)

$63,949,000 (14.80%)

$55,706,000 (17.77%)

$47,301,000 (30.25%)

Operating Expenses

$49,260,000 (-35.32%)

$76,159,000 (14.14%)

$66,723,000 (17.46%)

$56,806,000 (23.80%)

Interest Expense

$4,109,000 (22.33%)

$3,359,000 (22293.33%)

$15,000 (-99.62%)

$3,917,000 (121.68%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

-$60,015,000 (-29.37%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

-$60,015,000 (-29.37%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

-$60,015,000 (-29.37%)

Weighted Average Shares

$8,604,104 (24.78%)

$6,895,541 (17.69%)

$5,859,045 (67.12%)

$3,505,936 (45.83%)

Weighted Average Shares Diluted

$8,604,104 (24.78%)

$6,895,541 (17.69%)

$5,859,045 (67.12%)

$3,505,936 (45.83%)

Earning Before Interest & Taxes (EBIT)

-$47,493,000 (35.96%)

-$74,166,000 (-11.77%)

-$66,355,000 (-18.28%)

-$56,098,000 (-25.72%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$49,260,000 (35.32%)

-$76,159,000 (-14.14%)

-$66,723,000 (-17.46%)

-$56,806,000 (-23.80%)

MBIO Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$5,886,000 (299.39%)

-$2,952,000 (44.99%)

-$5,366,000 (-21.62%)

-$4,412,000 (-131.72%)

Net Cash Flow from Financing

-$26,081,000 (-176.58%)

$34,056,000 (-51.93%)

$70,847,000 (-9.31%)

$78,122,000 (19.97%)

Net Cash Flow from Operations

-$49,477,000 (23.96%)

-$65,066,000 (-21.24%)

-$53,667,000 (-43.81%)

-$37,319,000 (-11.13%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$69,672,000 (-105.15%)

-$33,962,000 (-387.47%)

$11,814,000 (-67.54%)

$36,391,000 (-19.92%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$5,936,000 (329.45%)

-$2,587,000 (35.10%)

-$3,986,000 (-107.06%)

-$1,925,000 (17.91%)

Issuance (Repayment) of Debt Securities

-$30,375,000 (-201.25%)

$30,000,000 (0%)

$0 (0%)

-$15,750,000 (-215.75%)

Issuance (Purchase) of Equity Shares

$4,739,000 (-30.60%)

$6,829,000 (-90.55%)

$72,228,000 (-25.83%)

$97,384,000 (79.87%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$568,000 (-75.12%)

$2,283,000 (-30.99%)

$3,308,000 (10.75%)

$2,987,000 (12.12%)

Depreciation Amortization & Accretion

$2,225,000 (-26.59%)

$3,031,000 (31.44%)

$2,306,000 (29.19%)

$1,785,000 (30.48%)

MBIO Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-433.10% (-304.77%)

-107.00% (-102.65%)

-52.80% (35.84%)

-82.30% (5.07%)

Return on Average Assets (ROAA)

-146.40% (-117.21%)

-67.40% (-38.40%)

-48.70% (26.66%)

-66.40% (-7.44%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-578.20% (-152.82%)

-228.70% (78.16%)

-1047.30% (-77.99%)

-588.40% (-157.84%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.23 (57.31%)

-0.53 (75.87%)

-2.18 (34.22%)

-3.32 (-4.96%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

101.16 (10944.10%)

0.92 (-33.62%)

1.38 (-45.00%)

2.51 (-21.69%)

Debt to Equity Ratio (D/E)

143.24 (14267.50%)

1 (774.56%)

0.11 (-1.72%)

0.12 (-72.51%)

Earnings Per Share (EPS)

-6 (46.67%)

-11.25 (1.32%)

-11.4 (33.33%)

-17.1 (11.63%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-5.06 (48.43%)

-9.81 (0.29%)

-9.84 (12.10%)

-11.19 (25.09%)

Book Value Per Share (BVPS)

0.01 (-99.79%)

6.71 (-65.02%)

19.18 (-31.67%)

28.08 (30.68%)

Tangible Assets Book Value Per Share (TABVPS)

2.06 (-84.62%)

13.4 (-37.26%)

21.36 (-31.85%)

31.35 (2.61%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (66.67%)

-3 (-50.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.1 (-139.54%)

0.26 (147.73%)

-0.55 (82.70%)

-3.19 (-28.12%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.74 (-85.86%)

5.22 (-49.47%)

10.33 (-1.26%)

10.46 (28.91%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$43,541,000 (35.64%)

-$67,653,000 (-17.35%)

-$57,653,000 (-46.91%)

-$39,244,000 (-9.24%)

Enterprise Value (EV)

$4,706,206 (125.15%)

-$18,710,569 (-153.00%)

$35,303,170 (-79.59%)

$172,969,166 (60.84%)

Earnings Before Tax (EBT)

-$51,602,000 (33.44%)

-$77,525,000 (-16.81%)

-$66,370,000 (-10.59%)

-$60,015,000 (-29.37%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$45,268,000 (36.36%)

-$71,135,000 (-11.06%)

-$64,049,000 (-17.93%)

-$54,313,000 (-25.57%)

Invested Capital

-$2,115,000 (-106.60%)

$32,039,000 (455.27%)

$5,770,000 (51.48%)

$3,809,000 (-79.73%)

Working Capital

-$4,025,000 (-106.31%)

$63,743,000 (-36.82%)

$100,891,000 (12.08%)

$90,019,000 (62.81%)

Tangible Asset Value

$17,742,000 (-80.80%)

$92,422,000 (-26.16%)

$125,170,000 (13.89%)

$109,900,000 (49.64%)

Market Capitalization

$12,443,206 (-70.64%)

$42,374,431 (-72.68%)

$155,090,170 (-37.19%)

$246,927,166 (49.20%)

Average Equity

$11,915,000 (-83.56%)

$72,484,250 (-42.36%)

$125,750,000 (72.45%)

$72,921,000 (36.29%)

Average Assets

$35,250,500 (-69.36%)

$115,031,000 (-15.56%)

$136,226,250 (50.79%)

$90,339,750 (20.30%)

Invested Capital Average

$8,214,500 (-74.67%)

$32,424,250 (411.75%)

$6,336,000 (-33.54%)

$9,534,000 (-51.24%)

Shares

9,217,190 (28.85%)

7,153,650 (14.85%)

6,228,552 (43.21%)

4,349,245 (60.83%)